Pulmonary Tuberculosis Treatment Failure in Coastal Poasia: Determinants from a Case-Control Study

Fitri Rachmillah Fadmi, Sri Mulyani, Karol Octrisdey, Wa Ode Sitti Justin, Yeni Riza

Abstract


Background: Tuberculosis continues to be a major public health issue, particularly in coastal areas where access to healthcare services is often constrained and living conditions differ from inland settings. Treatment failure remains a persistent challenge for tuberculosis control programs at the primary healthcare level. This study aimed to identify factors associated with pulmonary tuberculosis treatment failure in a coastal primary healthcare setting. Methods: An analytical observational study with a case–control design was conducted, involving 48 participants, comprising 24 cases (treatment failure) and 24 controls (treatment success). Data were obtained from tuberculosis program records and through structured interviews. Bivariate analysis using the chi-square test was performed to identify potential determinants (p ≤ 0.25), followed by binary logistic regression to determine factors independently associated with treatment failure. Results: Treatment adherence was the only factor that remained significantly associated with treatment failure after adjustment (AOR = 14.81; p = 0.016). Other variables, including distance to health facilities, knowledge, history of comorbid disease, family support, anxiety, and the role of the treatment supervisor (Pengawas Minum Obat or PMO), did not show significant associations in the multivariable model, although some demonstrated a tendency toward increased risk. Conclusion: Adherence to treatment plays a decisive role in determining tuberculosis treatment outcomes. Strengthening adherence should therefore be prioritized to reduce treatment failure, particularly in coastal communities where structural and social conditions may affect patients’ ability to complete treatment.


Full Text:

PDF

References


World Health Organization. Global Tuberculosis Report 2024. Geneva: World Health Organization; 2024.

MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward meeting global targets. The Lancet Infectious Diseases. 2020;20(4):440–454. https://doi.org/10.15585/mmwr.mm6911a2

Ministry of Health of Republic Indonesia. Profil Kesehatan Indonesia Tahun 2024. Jakarta: Ministry of Health of Republic Indonesia; 2024.

Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis. The Lancet Infectious Diseases. 2018;18(9):e307–e318. https://doi.org/10.1371/journal.pmed.1002595

Jomidava T, Khogali M, Sereda Y, Avaliani Z, Davitashvili M, Madzgharashvili M, et al. Does optimized adherence support improve treatment outcomes in RR/MDR-TB patients on 18–20 months regimen in Tbilisi, Georgia? The Journal of Infection in Developing Countries. 2021;15(91):34S. https://doi.org/10.3855/jidc.13783

Prasad, Malini Anna. Phylogenetic analysis of plants with antibacterial activity reveals certain plant families relevant for antibiotic drug discovery [Master's Thesis]. New York:Long Island University, The Brooklyn Center; 2018.

Tesema, Tariku, et al. Determinants of tuberculosis treatment outcome under directly observed treatment short courses in Adama City, Ethiopia. Plos one, 2020, 15.4: e0232468. https://doi.org/10.1371/journal.pone.0232468

Doltu S, Ciobanu A, Sereda Y, Persian R, Ravenscroft L, Kasyan L, et al. Short and long-term outcomes of video observed treatment in tuberculosis patients, the Republic of Moldova. The Journal of Infection in Developing Countries. 2021;15(09.1):17S-24S. https://doi.org/10.3855/jidc.14601

Story A. Tuberculosis Treatment and Adherence. In: Migliori GB, Raviglione MC, editors. Essential Tuberculosis. Cham: Springer International Publishing; 2021. https://doi.org/10.1007/978-3-030-66703-0_19

Teferi MY, El-Khatib Z, Boltena MT, Andualem AT, Asamoah BO, Biru M, et al. Tuberculosis treatment outcome and predictors in Africa: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2021;18(20):10678. https://doi.org/10.3390/ijerph182010678

Opperman C, Singh S, Ghebrekristos Y, Warren R, Goosen W. Pulmonary non-tuberculous mycobacteria and Mycobacterium tuberculosis complex co-infection: A pragmatic approach to its diagnosis and management in South Africa. South African Medical Journal. 2024;114(9):12–13. https://doi.org/10.7196/samj.2025.v115i3.3042

Southeast Sulawesi Provincial Health Office. Provincial health profile of Southeast Sulawesi, 2024. Kendari, Indonesia: Southeast Sulawesi Provincial Health Office; 2024.

Kendari City Health Office. Tuberculosis program report of Kendari City, 2024. Kendari, Indonesia: Kendari City Health Office; 2024.

Poasia Primary Health Center. Tuberculosis program report of Poasia Primary Health Center, 2024. Kendari, Indonesia: Poasia Primary Health Center; 2024.

Macpherson L, Miller C, Hamada Y, Rangaka L, Ruhwald M, Falzon D, et al. Policies, practices, opportunities and challenges for tuberculosis screening: a global survey of national tuberculosis programmes. BMJ Glob Health. 2025;10:e016000. https://doi.org/10.1136/bmjgh-2024-016000

Sulis G, Tavaziva G, Gore G, Benedetti A, Solomons R, van Toorn R, et al. Comparative Effectiveness of Regimens for Drug-Susceptible Tuberculous Meningitis in Children and Adolescents: A Systematic Review and Aggregate-Level Data Meta-Analysis, Open Forum Infectious Diseases. 2022;9(6):ofac108. https://doi.org/10.1093/ofid/ofac108

Rickman HM, Phiri MD, Feasey HR, Krutikov M, Shao H, Horton KC, et al. Sex differences in the risk of Mycobacterium tuberculosis infection: a systematic review and meta-analysis of population-based immunoreactivity surveys. Lancet Public Health. 2025;10(7):e588–e598. https://doi.org/10.1016/s2468-2667(25)00120-3

Montsi S. The epidemiology and treatment outcomes of tuberculosis cases in Lesotho between 2009 and 2019 [Dissertation]. Polokwane: University of Limpopo; 2021.

Maynard C, Tariq S, Sotgiu G, Migliori GB, van den Boom M, Field N. Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: a mixed methods systematic review and meta-analysis. EClinicalMedicine. 2023;61:102057. https://doi.org/10.1016/j.eclinm.2023.102057

Yanes-Lane M, Trajman A, Bastos ML, Oxlade O, Valiquette C, Rufino N, et al. Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation. BMC Public Health. 2021;21:177. https://doi.org/10.1186/s12889-021-10195-z

Fadmi, FR, Buton LD. The Correlation Between Individual Characteristics and Smear-Positive Pulmonary Tuberculosis In Puuwatu Health Center, Kendari City: Individual Characteristict And Tuberculosis. Indonesian Journal of Health Sciences Research and Development. 2021;3(1):223-229. https://doi.org/10.36566/ijhsrd/vol3.iss1/80

Fadmi, FR, Rahmawati R, Fitriyanti F, Mulyani S, Justin WOS. Logistic Regression Analysis for Pulmonary Tuberculosis Related to Environmental Factors in Katobu Health Centre: Pulmonary Tuberculosis Related to Environmental. Indonesian Journal Of Health Sciences Research And Development. 2025;7(1): 94-102. https://doi.org/10.36566/ijhsrd/vol7.iss1/301

McNabb KC, others. Travel distance to tuberculosis treatment and its impact on loss to follow-up. BMC Public Health. 2024;24:578. https://doi.org/10.1186/s12889-024-17924-0

Bonsa Z, Tadesse M, Bekele E, Abeba G, Solomon E, Husen M, et al. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Southwestern Oromia, Ethiopia: ten-year retrospective analysis. BMC Infectious Diseases. 2024;24:1305. https://doi.org/10.1186/s12879-024-10205-6

Arja A, Godana W, Hassen H, Bogale B. Patient delay and associated factors among tuberculosis patients in Gamo zone public health facilities, Southern Ethiopia: An institution-based cross-sectional study. PloS One. 2021;16(7):e0255327. https://doi.org/10.1371/journal.pone.0255327

Meiyanti M, Bachtiar A, Kusumaratna RK, Alfiyyah A, Machrumnizar M, Pusparini P. Tuberculosis treatment outcomes and associated factors: A retrospective study in West Nusa Tenggara, Indonesia. Narra J. 2024;4(3):e1660, http://dx.doi.org/10.52225/narra.v4i3.1660

Boutilier JJ, Jónasson JO, Yoeli E. Improving tuberculosis treatment adherence support: the case for targeted behavioral interventions. Manufacturing & Service Operations Management. 2022;24(6):2925–2943. https://doi.org/10.1287/msom.2021.1046

Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respiratory Research. 2021;22:251. https://doi.org/10.1186/s12931-021-01841-6

Dememew Z, Deribew A, Zegeye A, Janfa T, Kegne T, Alemayehu Y, et al. A high burden of infectious tuberculosis cases among older children and young adolescents of the female gender in Ethiopia. Tropical Medicine and Infectious Disease. 2025;10(3):79. https://doi.org/10.3390/tropicalmed10030079

Magee MJ, Khakharia A, Gandhi NR, Day CL, Kornfeld H, Rhee MK, et al. Increased risk of incident diabetes among individuals with latent tuberculosis infection. Diabetes Care. 2022;45(4):880–887. https://doi.org/10.2337/dc21-1687

Alinaitwe et al. B. Family support and tuberculosis treatment adherence. Scientific Reports. 2025;15(1):11150. https://doi.org/10.1038/s41598-025-96260-8

Loveday M, Hlangu S, Larkan LM, Cox H, Daniels J, Mohr-Holland E, et al. “This is not my body”: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis. PLoS One. 2021;16(10):e0251482. https://doi.org/10.1371/journal.pone.0251482

Sweetland AC, Mann CG, Fernandes MJ, Matsuzaka C, De Silva FV, Lee J, et al. Leveraging Social Networks to Integrate Depression Treatmentinto Primary Health and Tuberculosis Care in Brazil. Current Psychiatry Research and Reviews. 2024;20(4):350-365. https://doi.org/10.2174/0126660822243332230921052022

Sun G, Wang K, Li X, Yin T, Hu H, Zhang L, et al. Construction of Health Education Prescriptions for Patients with Tuberculosis. In: Proceedings of the 2024 International Conference on Smart Healthcare and Wearable Intelligent Devices. Guangzhou Guangdong China: ACM; 2024:288-296. https://doi.org/10.1145/3703847.3703896

Plokhykh V, Duka M, Cassidy L, Chen CY, Malakyan K, Isaakidis P, et al. Mental health interventions for rifampicin-resistant tuberculosis patients with alcohol use disorders, Zhytomyr, Ukraine. The Journal of Infection in Developing Countries. 2021;15(09.1):25S-33S. https://doi.org/10.3855/jidc.13827

Wagnew F, Gray D, Tsheten T, Kelly M, Clements AC, Alene KA. Effectiveness of nutritional support to improve treatment adherence in patients with tuberculosis: a systematic review. Nutrition Reviews. 2024;82(9):1216–1225. https://doi.org/10.1093/nutrit/nuad120

Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, Abd El Aziz MS, et al. Drug-resistant tuberculosis: a persistent global health concern. Nature Reviews Microbiology. 2024;22(10):617–635. https://doi.org/10.1038/s41579-024-01025-1




DOI: https://doi.org/10.33846/hd21104

Refbacks

  • There are currently no refbacks.




____________________________________________________________________________________________________________________________________________

Health Dynamics || Open Access Journal || Online version only || Publisher: Knowledge Dynamics || ISSN: 3006-5518 (online) || Contact: healthdynamics.journal@gmail.com; +8801814901991; +6282136364408